Laboratory of Forensic Medicine and Toxicology (Medical Law and Ethics), School of Medicine, Faculty of Health Sciences, Aristotle University, University Campus, Postal Code 541 24, Thessaloniki, Greece.
Cuad Bioet. 2023 May-Aug;34(111):189-218. doi: 10.30444/CB.153.
As health-related big data research (HRBDR) has drastically increased over the last years due to the rapid development of big data analytics, a range of important ethical issues are raised. In this study, a systematic literature review was conducted. Several and interesting results emerged from this review. The term ″big data″ has not yet been clearly defined. The already existing ethical principles and concepts need to be revisited in the new HRBDR context. Traditional research ethics notions like privacy and informed consent are to be reconsidered. HRBDR creates new ethical issues such those related to trust / trustworthiness and public values such as reciprocity, transparency, inclusivity and common good. The implementation of dynamic consent rather than broad consent is currently highlighted as the more satisfying solution. Ethical review committees in their current form are ill-suited to provide exclusive ethical oversight on HRBDR projects. Expanding Ethical Review Committees' purview and members' expertise, as well as creating novel oversight bodies by promoting a co-governance system including public and all the stakeholders involved are strongly recommended. The mechanism of ″social licence″, that is, informal permissions granted to researchers by society, can serve as a guideline. High-stakes decisions are often made under uncertainty. Machine learning algorithms are highly complex and in some cases opaque, and may yield biased decisions or discrimination. Improved interdisciplinary dialogue along with considering aspects like auditing, benchmarking, confidence / trust and explainability /interpretability may address concerns about HRBDR ethics. Finally and most importantly, research ethics shifts towards a population-based model of ethics.
由于大数据分析的快速发展,近年来与健康相关的大数据研究(HRBDR)急剧增加,由此引发了一系列重要的伦理问题。在本研究中,我们进行了系统的文献回顾。从这次审查中出现了一些有趣的结果。“大数据”一词尚未明确定义。现有的伦理原则和概念需要在新的 HRBDR 背景下重新审视。像隐私和知情同意这样的传统研究伦理概念需要重新考虑。HRBDR 引发了一些新的伦理问题,如信任/可信度问题以及公共价值观,如互惠、透明度、包容性和共同利益。目前,人们强调实施动态同意而不是广泛同意作为更令人满意的解决方案。目前的伦理审查委员会不适合对 HRBDR 项目进行独家的伦理监督。强烈建议扩大伦理审查委员会的职权范围和成员的专业知识,并通过创建包括公众和所有相关利益相关者在内的共同治理系统来创建新的监督机构。“社会许可”机制,即社会授予研究人员的非正式许可,可以作为指导方针。高风险决策往往是在不确定的情况下做出的。机器学习算法非常复杂,在某些情况下是不透明的,并且可能导致有偏差的决策或歧视。通过改进跨学科对话,同时考虑审计、基准测试、信心/信任和可解释性/可解释性等方面,可以解决对 HRBDR 伦理的担忧。最后也是最重要的是,研究伦理转向基于人群的伦理模式。